Format

Send to

Choose Destination
Arch Esp Urol. 2010 Jun;63(5):392-5.

Sertoli cell tumor, a rare testicular tumor, our experience and review of the literature.

[Article in English, Spanish]

Author information

1
Urology Department Hospital Virgen de la Salud, Toledo, Spain. naggoga@yahoo.es <naggoga@yahoo.es>

Abstract

OBJECTIVE:

We report two new cases of Sertoli cell testicular tumors, and a Cochrane and Medline search of cases published worldwide.

METHODS:

We reviewed our series of testicular tumors, the stromal tumor incidence, clinical presentation, treatment and prognosis, and the experience reflected in the literature.

RESULTS:

The prevalence of testicular tumors in our health area is of 0.09%, and 2.3% of them are Sertoli cell neoplasms. This figure is slightly higher than the found in other series in which Sertoli tumors range from 0.4% to 1.5% of testicular malignancies in adults and reach 4% in children.

CONCLUSIONS:

Sertoli cell tumor has an incidence not exceeding 4%. The most common symptom is a painless mass; in cases with endocrine manifestation, up to 10% are malignant depending on the age of the patient.

PMID:
20587845
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Archivos Espanoles de Urologia
Loading ...
Support Center